1,638 reports of this reaction
2.2% of all TORSEMIDE reports
#7 most reported adverse reaction
DEATH is the #7 most commonly reported adverse reaction for TORSEMIDE, manufactured by Sarfez Pharmaceuticals Inc. There are 1,638 FDA adverse event reports linking TORSEMIDE to DEATH. This represents approximately 2.2% of all 74,224 adverse event reports for this drug.
TORSEMIDE has an overall safety score of 85 out of 100. Patients taking TORSEMIDE who experience death should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
DEATH is a less commonly reported adverse event for TORSEMIDE, but still significant enough to appear in the safety profile.
In addition to death, the following adverse reactions have been reported for TORSEMIDE:
The following drugs have also been linked to death in FDA adverse event reports:
DEATH has been reported as an adverse event in 1,638 FDA reports for TORSEMIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
DEATH accounts for approximately 2.2% of all adverse event reports for TORSEMIDE, making it a notable side effect.
If you experience death while taking TORSEMIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.